(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IGFBP1 mRNA] CTD PMID:31150632 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 1,1-dichloroethene decreases expression ISO RGD:69039 6480464 vinylidene chloride results in decreased expression of IGFBP1 mRNA CTD PMID:26682919 1-methylphenanthrene multiple interactions ISO RGD:69038 6480464 [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of IGFBP1 mRNA CTD PMID:17690111 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of IGFBP1 mRNA CTD PMID:17522070 more ... 1-naphthyl isothiocyanate multiple interactions ISO RGD:69038 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of IGFBP1 mRNA CTD PMID:27344345 1-naphthyl isothiocyanate increases expression ISO RGD:69039 6480464 1-Naphthylisothiocyanate results in increased expression of IGFBP1 mRNA CTD PMID:15913567 17alpha-ethynylestradiol increases expression ISO RGD:69039 6480464 Ethinyl Estradiol results in increased expression of IGFBP1 mRNA CTD PMID:14976129 17alpha-ethynylestradiol multiple interactions ISO RGD:69039 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IGFBP1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of IGFBP1 mRNA CTD PMID:15795090 17beta-estradiol multiple interactions ISO RGD:69038 6480464 [Cyclic AMP co-treated with Estradiol co-treated with Progesterone] results in increased expression of IGFBP1 mRNA more ... CTD PMID:11756571 more ... 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of IGFBP1 mRNA CTD PMID:32145629 17beta-estradiol decreases expression ISO RGD:69038 6480464 Estradiol results in decreased expression of IGFBP1 mRNA CTD PMID:31646340 17beta-estradiol increases expression ISO RGD:69038 6480464 Estradiol results in increased expression of IGFBP1 mRNA, Estradiol results in increased expression of IGFBP1 protein CTD PMID:12154049 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:69038 6480464 Dihydrotestosterone results in increased expression of IGFBP1 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:69039 6480464 2 more ... CTD PMID:30294300 2,2'-bipyridine increases expression ISO RGD:69038 6480464 2, 2'-Dipyridyl results in increased expression of IGFBP1 mRNA CTD PMID:19924283 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69039 6480464 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA] more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:69039 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69038 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA, Tetrachlorodibenzodioxin results in increased expression of IGFBP1 protein CTD PMID:15056799 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA] CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69039 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA, Tetrachlorodibenzodioxin results in increased expression of IGFBP1 protein CTD PMID:16960034 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:69038 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69039 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP1 mRNA CTD PMID:17949056 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of IGFBP1 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-galactopyranose increases expression EXP 6480464 Galactosamine results in increased expression of IGFBP1 mRNA CTD PMID:11779202 2-butoxyethanol increases expression ISO RGD:69039 6480464 n-butoxyethanol results in increased expression of IGFBP1 mRNA CTD PMID:19812364 2-hydroxy-17beta-estradiol increases expression ISO RGD:69038 6480464 2-hydroxyestradiol results in increased expression of IGFBP1 mRNA CTD PMID:32781018 2-hydroxy-17beta-estradiol multiple interactions ISO RGD:69038 6480464 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:32781018 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of IGFBP1 mRNA CTD PMID:15890375 28-Homobrassinolide increases expression EXP 6480464 homobrassinolide results in increased expression of IGFBP1 mRNA CTD PMID:21491949 3',5'-cyclic AMP multiple interactions ISO RGD:69038 6480464 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] more ... CTD PMID:31953017 more ... 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:19692669 , PMID:20959002 3-chloropropane-1,2-diol multiple interactions ISO RGD:69039 6480464 [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of IGFBP1 mRNA CTD PMID:33187795 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of IGFBP1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of IGFBP1 mRNA CTD PMID:18289764 , PMID:25380136 4,4'-sulfonyldiphenol decreases expression ISO RGD:69039 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of IGFBP1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO RGD:69038 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of IGFBP1 gene CTD PMID:31601247 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IGFBP1 mRNA CTD PMID:15890375 4-hydroxy-17beta-estradiol increases expression ISO RGD:69038 6480464 4-hydroxyestradiol results in increased expression of IGFBP1 mRNA CTD PMID:32781018 4-hydroxy-17beta-estradiol multiple interactions ISO RGD:69038 6480464 4-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:32781018 4-hydroxyphenyl retinamide increases expression ISO RGD:69039 6480464 Fenretinide results in increased expression of IGFBP1 mRNA CTD PMID:28973697 5-azacytidine multiple interactions ISO RGD:69038 6480464 Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA], Azacitidine promotes the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 protein] CTD PMID:20823114 5-azacytidine increases expression ISO RGD:69038 6480464 Azacitidine results in increased expression of IGFBP1 mRNA CTD PMID:20823114 8-Br-cAMP increases secretion ISO RGD:69038 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased secretion of IGFBP1 protein CTD PMID:21273127 8-Br-cAMP increases expression ISO RGD:69038 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA, 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 protein CTD PMID:17065600 more ... 8-Br-cAMP decreases expression ISO RGD:69038 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IGFBP1 mRNA, 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IGFBP1 protein CTD PMID:18815356 8-Br-cAMP multiple interactions ISO RGD:69038 6480464 1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] more ... CTD PMID:16709600 more ... afimoxifene increases expression ISO RGD:69038 6480464 afimoxifene results in increased expression of IGFBP1 mRNA CTD PMID:12154049 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of IGFBP1 mRNA CTD PMID:15890375 , PMID:25378103 aflatoxin B1 decreases methylation ISO RGD:69038 6480464 Aflatoxin B1 results in decreased methylation of IGFBP1 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:69038 6480464 Aflatoxin B1 results in increased expression of IGFBP1 mRNA CTD PMID:21632981 more ... aflatoxin B1 affects expression ISO RGD:69038 6480464 Aflatoxin B1 affects the expression of IGFBP1 protein CTD PMID:20106945 amiodarone increases expression ISO RGD:69038 6480464 Amiodarone results in increased expression of IGFBP1 mRNA CTD PMID:27089845 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IGFBP1 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of IGFBP1 mRNA CTD PMID:15183010 Archazolid B increases expression ISO RGD:69038 6480464 archazolid B results in increased expression of IGFBP1 mRNA CTD PMID:25218289 aristolochic acids increases expression EXP 6480464 Aristolochic Acids results in increased expression of IGFBP1 mRNA CTD PMID:19717638 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of IGFBP1 mRNA CTD PMID:18178546 arsenite(3-) multiple interactions ISO RGD:69038 6480464 Fulvestrant inhibits the reaction [arsenite results in decreased expression of IGFBP1 mRNA] CTD PMID:31646340 arsenite(3-) decreases expression ISO RGD:69038 6480464 arsenite results in decreased expression of IGFBP1 mRNA CTD PMID:31646340 arsenous acid multiple interactions ISO RGD:69038 6480464 [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP1 protein CTD PMID:27430728 arsenous acid increases expression ISO RGD:69039 6480464 Arsenic Trioxide results in increased expression of IGFBP1 mRNA CTD PMID:15073043 atazanavir sulfate multiple interactions ISO RGD:69038 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IGFBP1 mRNA CTD PMID:33819548 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA CTD PMID:33854195 bacitracin increases expression EXP 6480464 Bacitracin results in increased expression of IGFBP1 mRNA CTD PMID:18289764 benzo[a]pyrene decreases expression ISO RGD:69039 6480464 Benzo(a)pyrene results in decreased expression of IGFBP1 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:69038 6480464 Benzo(a)pyrene results in increased methylation of IGFBP1 exon, Benzo(a)pyrene results in increased methylation of IGFBP1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:69038 6480464 Benzo(a)pyrene results in increased expression of IGFBP1 mRNA, Benzo(a)pyrene results in increased expression of IGFBP1 protein CTD PMID:16269432 more ... benzo[a]pyrene multiple interactions ISO RGD:69038 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 benzo[a]pyrene diol epoxide I increases expression ISO RGD:69038 6480464 7 more ... CTD PMID:26238291 benzo[b]fluoranthene multiple interactions ISO RGD:69038 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGFBP1 mRNA CTD PMID:17690111 benzo[b]fluoranthene increases expression ISO RGD:69038 6480464 benzo(b)fluoranthene results in increased expression of IGFBP1 mRNA CTD PMID:16269432 beta-naphthoflavone increases expression ISO RGD:69038 6480464 beta-Naphthoflavone results in increased expression of IGFBP1 mRNA CTD PMID:19737606 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of IGFBP1 mRNA CTD PMID:16648578 bicalutamide multiple interactions ISO RGD:69038 6480464 [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein CTD PMID:16847815 bis(2-ethylhexyl) phthalate increases expression ISO RGD:69039 6480464 Diethylhexyl Phthalate results in increased expression of IGFBP1 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:69039 6480464 PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IGFBP1 mRNA] CTD PMID:19850644 bisphenol A increases expression ISO RGD:69038 6480464 bisphenol A results in increased expression of IGFBP1 mRNA, bisphenol A results in increased expression of IGFBP1 protein CTD PMID:21273127 more ... bisphenol A increases expression ISO RGD:69039 6480464 bisphenol A results in increased expression of IGFBP1 mRNA CTD PMID:30245210 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of IGFBP1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:69039 6480464 bisphenol A results in decreased expression of IGFBP1 mRNA CTD PMID:30951980 bisphenol A affects expression ISO RGD:69038 6480464 bisphenol A affects the expression of IGFBP1 mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IGFBP1 mRNA CTD PMID:30816183 more ... bisphenol A multiple interactions ISO RGD:69038 6480464 [Progesterone co-treated with bisphenol A] results in increased expression of IGFBP1 mRNA CTD PMID:26604029 bisphenol A increases secretion ISO RGD:69038 6480464 bisphenol A results in increased secretion of IGFBP1 protein CTD PMID:26604029 bisphenol F decreases expression ISO RGD:69039 6480464 bisphenol F results in decreased expression of IGFBP1 mRNA CTD PMID:30951980 bucladesine increases expression ISO RGD:69038 6480464 Bucladesine results in increased expression of IGFBP1 CTD PMID:12093828 bucladesine multiple interactions ISO RGD:69038 6480464 [Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA more ... CTD PMID:20823114 , PMID:30328349 butan-1-ol multiple interactions ISO RGD:69038 6480464 1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] CTD PMID:17065600 butanal decreases expression ISO RGD:69038 6480464 butyraldehyde results in decreased expression of IGFBP1 mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of IGFBP1 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:69038 6480464 Fulvestrant inhibits the reaction [Cadmium results in decreased expression of IGFBP1 mRNA] CTD PMID:31646340 cadmium atom decreases expression ISO RGD:69038 6480464 Cadmium results in decreased expression of IGFBP1 mRNA CTD PMID:31646340 cadmium dichloride increases expression ISO RGD:69038 6480464 Cadmium Chloride results in increased expression of IGFBP1 protein CTD PMID:26138014 cadmium dichloride multiple interactions ISO RGD:69038 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IGFBP1 protein] CTD PMID:26138014 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of IGFBP1 mRNA CTD PMID:25993096 caffeine increases expression ISO RGD:69038 6480464 Caffeine results in increased expression of IGFBP1 mRNA CTD PMID:11793227 calcitriol increases expression ISO RGD:69038 6480464 Calcitriol results in increased expression of IGFBP1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:69038 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of IGFBP1 mRNA CTD PMID:21592394 cannabidiol multiple interactions ISO RGD:69038 6480464 Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:31953017 carbamazepine affects expression ISO RGD:69038 6480464 Carbamazepine affects the expression of IGFBP1 mRNA CTD PMID:24752500 chenodeoxycholic acid decreases expression ISO RGD:69039 6480464 Chenodeoxycholic Acid results in decreased expression of IGFBP1 mRNA CTD PMID:19072826 chenodeoxycholic acid multiple interactions ISO RGD:69038 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA more ... CTD PMID:33819548 chlorpromazine increases expression ISO RGD:69038 6480464 Chlorpromazine results in increased expression of IGFBP1 mRNA CTD PMID:15924885 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA CTD PMID:33854195 cholesterol multiple interactions ISO RGD:69039 6480464 [Cholesterol co-treated with 1, 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IGFBP1 mRNA CTD PMID:22129739 choline multiple interactions ISO RGD:69039 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGFBP1 mRNA CTD PMID:20938992 chromium(3+) trichloride decreases expression ISO RGD:69039 6480464 chromic chloride results in decreased expression of IGFBP1 mRNA CTD PMID:12153762 ciguatoxin CTX1B affects expression ISO RGD:69039 6480464 Ciguatoxins affects the expression of IGFBP1 mRNA CTD PMID:18353800 ciprofibrate increases expression ISO RGD:69039 6480464 ciprofibrate results in increased expression of IGFBP1 mRNA CTD PMID:12771043 cisplatin affects expression EXP 6480464 Cisplatin affects the expression of IGFBP1 mRNA CTD PMID:18289764 cisplatin multiple interactions ISO RGD:69038 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of IGFBP1 mRNA CTD PMID:27392435 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of IGFBP1 mRNA CTD PMID:17522070 clofibrate decreases expression ISO RGD:69039 6480464 Clofibrate results in decreased expression of IGFBP1 mRNA CTD PMID:17585979 , PMID:23811191 clofibrate multiple interactions ISO RGD:69039 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA] CTD PMID:17585979 clofibrate increases expression ISO RGD:69039 6480464 Clofibrate results in increased expression of IGFBP1 mRNA CTD PMID:11356909 clotrimazole increases expression ISO RGD:69038 6480464 Clotrimazole results in increased expression of IGFBP1 mRNA CTD PMID:12659874 clotrimazole increases secretion ISO RGD:69038 6480464 Clotrimazole results in increased secretion of IGFBP1 protein CTD PMID:12659874 clozapine increases expression ISO RGD:69038 6480464 Clozapine results in increased expression of IGFBP1 protein CTD PMID:36482696 cobalt dichloride increases expression ISO RGD:69039 6480464 cobaltous chloride results in increased expression of IGFBP1 mRNA, cobaltous chloride results in increased expression of IGFBP1 protein CTD PMID:16990490 cobalt dichloride decreases expression ISO RGD:69039 6480464 cobaltous chloride results in decreased expression of IGFBP1 mRNA CTD PMID:21139344 colforsin daropate hydrochloride increases expression ISO RGD:69038 6480464 Colforsin results in increased expression of IGFBP1 CTD PMID:12093828 colforsin daropate hydrochloride multiple interactions ISO RGD:69038 6480464 [Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of IGFBP1 mRNA CTD PMID:31154070 copper(II) sulfate increases expression ISO RGD:69038 6480464 Copper Sulfate results in increased expression of IGFBP1 mRNA CTD PMID:19549813 corn oil affects expression EXP 6480464 Corn Oil affects the expression of IGFBP1 mRNA CTD PMID:16360708 cortisol multiple interactions ISO RGD:69038 6480464 Hydrocortisone promotes the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]] CTD PMID:23275455 curcumin multiple interactions ISO RGD:69038 6480464 [arsenic trioxide co-treated with Curcumin] results in decreased expression of IGFBP1 protein CTD PMID:27430728 cyanamide multiple interactions EXP 6480464 Cyanamide inhibits the reaction [Ethanol results in increased expression of IGFBP1 mRNA] CTD PMID:12394292 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of IGFBP1 mRNA CTD PMID:21865292 cyclosporin A multiple interactions ISO RGD:69038 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of IGFBP1 mRNA CTD PMID:33819548 cyclosporin A increases expression ISO RGD:69038 6480464 Cyclosporine results in increased expression of IGFBP1 mRNA CTD PMID:20106945 more ... cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of IGFBP1 mRNA CTD PMID:21865292 cypermethrin decreases expression ISO RGD:69039 6480464 cypermethrin results in decreased expression of IGFBP1 mRNA, cypermethrin results in decreased expression of IGFBP1 protein CTD PMID:36116546 deoxycholic acid decreases expression ISO RGD:69038 6480464 Deoxycholic Acid results in decreased expression of IGFBP1 mRNA CTD PMID:27089845 deoxycholic acid multiple interactions ISO RGD:69038 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA more ... CTD PMID:33819548 dexamethasone multiple interactions ISO RGD:69038 6480464 [Dexamethasone results in increased phosphorylation of and results in increased activity of NR3C1 protein] which results in increased expression of IGFBP1 mRNA, Dexamethasone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] CTD PMID:18483179 , PMID:23275455 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of IGFBP1 mRNA CTD PMID:17522070 diarsenic trioxide increases expression ISO RGD:69039 6480464 Arsenic Trioxide results in increased expression of IGFBP1 mRNA CTD PMID:15073043 diarsenic trioxide multiple interactions ISO RGD:69038 6480464 [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP1 protein CTD PMID:27430728 dibenz[a,h]anthracene increases expression ISO RGD:69038 6480464 1 more ... CTD PMID:16269432 dibenz[a,h]anthracene decreases expression ISO RGD:69039 6480464 1 more ... CTD PMID:26377693 dibenz[a,h]anthracene multiple interactions ISO RGD:69038 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 dibenzo[a,l]pyrene increases expression ISO RGD:69038 6480464 dibenzo(a, l)pyrene results in increased expression of IGFBP1 mRNA CTD PMID:16269432 dibenzo[a,l]pyrene multiple interactions ISO RGD:69038 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] affects the expression of IGFBP1 mRNA CTD PMID:17690111 dichloroacetic acid increases expression ISO RGD:69039 6480464 Dichloroacetic Acid results in increased expression of IGFBP1 mRNA CTD PMID:28962523 diclofenac affects expression ISO RGD:69038 6480464 Diclofenac affects the expression of IGFBP1 mRNA CTD PMID:24752500 diclofenac increases expression ISO RGD:69039 6480464 Diclofenac results in increased expression of IGFBP1 mRNA CTD PMID:26934552 diethylstilbestrol multiple interactions ISO RGD:69039 6480464 [Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of IGFBP1 mRNA CTD PMID:19665456 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of IGFBP1 mRNA CTD PMID:15890375 dimethylarsinic acid increases expression ISO RGD:69039 6480464 Cacodylic Acid results in increased expression of IGFBP1 mRNA CTD PMID:15345372 dioxygen increases expression ISO RGD:69038 6480464 Oxygen deficiency results in increased expression of IGFBP1 mRNA CTD PMID:19924283 doxorubicin increases expression ISO RGD:69039 6480464 Doxorubicin results in increased expression of IGFBP1 protein CTD PMID:30517846 doxorubicin increases expression ISO RGD:69038 6480464 Doxorubicin results in increased expression of IGFBP1 mRNA CTD PMID:29803840 enalapril increases expression EXP 6480464 Enalapril results in increased expression of IGFBP1 mRNA CTD PMID:12883983 epoxiconazole increases expression ISO RGD:69039 6480464 epoxiconazole results in increased expression of IGFBP1 mRNA CTD PMID:35436446 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of IGFBP1 mRNA CTD PMID:17522070 ethanol decreases expression ISO RGD:69039 6480464 Ethanol results in decreased expression of IGFBP1 mRNA CTD PMID:19167417 ethanol increases expression EXP 6480464 Ethanol results in increased expression of IGFBP1 mRNA CTD PMID:12394292 ethanol multiple interactions EXP 6480464 Cyanamide inhibits the reaction [Ethanol results in increased expression of IGFBP1 mRNA] CTD PMID:12394292 folic acid multiple interactions ISO RGD:69039 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGFBP1 mRNA CTD PMID:20938992 fulvestrant increases expression ISO RGD:69038 6480464 Fulvestrant results in increased expression of IGFBP1 mRNA CTD PMID:31646340 fulvestrant multiple interactions ISO RGD:69038 6480464 Fulvestrant inhibits the reaction [arsenite results in decreased expression of IGFBP1 mRNA] more ... CTD PMID:31646340 fumonisin B1 increases expression ISO RGD:69039 6480464 fumonisin B1 results in increased expression of IGFBP1 mRNA CTD PMID:16221962 furan increases expression ISO RGD:69039 6480464 furan results in increased expression of IGFBP1 mRNA CTD PMID:24183702 furan decreases expression EXP 6480464 furan results in decreased expression of IGFBP1 mRNA CTD PMID:26194646 genistein decreases expression EXP 6480464 Genistein results in decreased expression of IGFBP1 mRNA CTD PMID:17049845 genistein increases expression EXP 6480464 Genistein results in increased expression of IGFBP1 mRNA CTD PMID:15795090 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of IGFBP1 mRNA CTD PMID:18289764 glycidol multiple interactions ISO RGD:69039 6480464 [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of IGFBP1 mRNA CTD PMID:33187795 glycochenodeoxycholic acid multiple interactions ISO RGD:69038 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO RGD:69038 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:69038 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA more ... CTD PMID:33819548 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA CTD PMID:33854195 GW 4064 increases expression ISO RGD:69039 6480464 GW 4064 results in increased expression of IGFBP1 mRNA CTD PMID:26655953 hydrogen peroxide multiple interactions EXP 6480464 Hydrogen Peroxide inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] CTD PMID:17213664 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA CTD PMID:33854195 indirubin increases expression ISO RGD:69038 6480464 indirubin results in increased expression of IGFBP1 mRNA CTD PMID:15056799 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA, Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] CTD PMID:22129741 inulin multiple interactions ISO RGD:69039 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGFBP1 mRNA CTD PMID:36331819 ketamine increases expression EXP 6480464 Ketamine results in increased expression of IGFBP1 mRNA CTD PMID:20080153 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of IGFBP1 mRNA CTD PMID:18289764 kynurenine increases expression ISO RGD:69038 6480464 Kynurenine results in increased expression of IGFBP1 mRNA CTD PMID:32781018 kynurenine multiple interactions ISO RGD:69038 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Kynurenine promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]], Kynurenine promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:32781018 L-methionine multiple interactions ISO RGD:69039 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGFBP1 mRNA CTD PMID:20938992 L-tryptophan increases expression ISO RGD:69038 6480464 Tryptophan results in increased expression of IGFBP1 mRNA CTD PMID:32781018 L-tryptophan multiple interactions ISO RGD:69038 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]] more ... CTD PMID:32781018 lead diacetate decreases expression ISO RGD:69039 6480464 lead acetate results in decreased expression of IGFBP1 mRNA CTD PMID:25270620 lead diacetate increases expression ISO RGD:69039 6480464 lead acetate results in increased expression of IGFBP1 mRNA CTD PMID:21335049 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of IGFBP1 mRNA CTD PMID:24136188 leflunomide increases expression ISO RGD:69038 6480464 leflunomide results in increased expression of IGFBP1 mRNA CTD PMID:28988120 lipopolysaccharide decreases expression ISO RGD:69039 6480464 Lipopolysaccharides results in decreased expression of IGFBP1 mRNA CTD PMID:27339419 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of IGFBP1 mRNA CTD PMID:11779202 lisinopril dihydrate increases expression ISO RGD:69038 6480464 Lisinopril results in increased expression of IGFBP1 protein CTD PMID:9663927 medroxyprogesterone acetate multiple interactions ISO RGD:69038 6480464 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] more ... CTD PMID:11756571 more ... medroxyprogesterone acetate increases expression ISO RGD:69038 6480464 Medroxyprogesterone Acetate results in increased expression of IGFBP1 mRNA CTD PMID:11756571 , PMID:20685861 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of IGFBP1 mRNA CTD PMID:7540432 metformin decreases expression ISO RGD:69038 6480464 Metformin results in decreased expression of IGFBP1 mRNA CTD PMID:21316309 metformin decreases expression EXP 6480464 Metformin results in decreased expression of IGFBP1 mRNA CTD PMID:31324951 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of IGFBP1 mRNA CTD PMID:15120968 , PMID:15890375 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of IGFBP1 mRNA CTD PMID:30467583 methylarsonic acid increases expression ISO RGD:69039 6480464 monomethylarsonic acid results in increased expression of IGFBP1 mRNA CTD PMID:15345372 methylmercury(1+) decreases expression EXP 6480464 methylmercury II results in decreased expression of IGFBP1 mRNA CTD PMID:17905399 microcystin-LR increases expression ISO RGD:69039 6480464 cyanoginosin LR results in increased expression of IGFBP1 mRNA CTD PMID:17654400 mifepristone multiple interactions ISO RGD:69038 6480464 Mifepristone inhibits the reaction [Progesterone results in increased secretion of IGFBP1 protein] CTD PMID:26604029 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] CTD PMID:22129741 N-acetyl-L-cysteine multiple interactions ISO RGD:69038 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IGFBP1 protein] CTD PMID:26138014 N-nitrosodiethylamine increases expression ISO RGD:69038 6480464 Diethylnitrosamine results in increased expression of IGFBP1 mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA, Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] CTD PMID:22129741 N-nitrosodiethylamine increases expression ISO RGD:69039 6480464 Diethylnitrosamine results in increased expression of IGFBP1 mRNA CTD PMID:12771043 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of IGFBP1 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions ISO RGD:69039 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of IGFBP1 mRNA, MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of IGFBP1 mRNA] CTD PMID:17942915 , PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of IGFBP1 mRNA CTD PMID:15890375 , PMID:25380136 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of IGFBP1 mRNA CTD PMID:17072980 N-Nitrosopyrrolidine increases expression ISO RGD:69038 6480464 N-Nitrosopyrrolidine results in increased expression of IGFBP1 mRNA CTD PMID:32234424 NAD zwitterion increases expression ISO RGD:69038 6480464 NAD results in increased expression of IGFBP1 mRNA CTD PMID:32781018 NAD zwitterion multiple interactions ISO RGD:69038 6480464 NAD inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:32781018 NAD(+) multiple interactions ISO RGD:69038 6480464 NAD inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:32781018 NAD(+) increases expression ISO RGD:69038 6480464 NAD results in increased expression of IGFBP1 mRNA CTD PMID:32781018 nefazodone multiple interactions ISO RGD:69038 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IGFBP1 mRNA CTD PMID:33819548 nickel dichloride increases expression ISO RGD:69038 6480464 nickel chloride results in increased expression of IGFBP1 mRNA CTD PMID:21455298 nicotinamide multiple interactions ISO RGD:69039 6480464 Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA] CTD PMID:16917544 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of IGFBP1 mRNA CTD PMID:27592368 , PMID:33484710 ochratoxin A decreases expression ISO RGD:69038 6480464 ochratoxin A results in decreased expression of IGFBP1 mRNA, ochratoxin A results in decreased expression of IGFBP1 protein CTD PMID:19287073 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of IGFBP1 mRNA CTD PMID:19717638 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of IGFBP1 mRNA CTD PMID:23665939 oxazepam increases expression ISO RGD:69039 6480464 Oxazepam results in increased expression of IGFBP1 mRNA, Oxazepam results in increased expression of IGFBP1 protein CTD PMID:12727805 , PMID:15618236 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of IGFBP1 mRNA CTD PMID:23439660 ozone decreases expression ISO RGD:69039 6480464 Ozone results in decreased expression of IGFBP1 mRNA CTD PMID:16183385 paracetamol increases expression ISO RGD:69039 6480464 Acetaminophen results in increased expression of IGFBP1 mRNA CTD PMID:17585979 paracetamol multiple interactions ISO RGD:69038 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of IGFBP1 mRNA CTD PMID:33819548 paracetamol affects expression ISO RGD:69039 6480464 Acetaminophen affects the expression of IGFBP1 mRNA CTD PMID:15606129 , PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of IGFBP1 mRNA CTD PMID:15120968 more ... paracetamol increases expression ISO RGD:69038 6480464 Acetaminophen results in increased expression of IGFBP1 mRNA CTD PMID:11793227 , PMID:29067470 paracetamol multiple interactions ISO RGD:69039 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA] CTD PMID:17585979 paraquat multiple interactions EXP 6480464 Paraquat inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] CTD PMID:17213664 perfluorononanoic acid increases expression ISO RGD:69038 6480464 perfluoro-n-nonanoic acid results in increased expression of IGFBP1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:69038 6480464 perfluorooctane sulfonic acid results in increased expression of IGFBP1 mRNA CTD PMID:33772556 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:69039 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGFBP1 mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:69038 6480464 perfluorooctanoic acid results in decreased expression of IGFBP1 protein CTD PMID:26879310 perfluorooctanoic acid increases expression ISO RGD:69038 6480464 perfluorooctanoic acid results in increased expression of IGFBP1 mRNA CTD PMID:33772556 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of IGFBP1 mRNA CTD PMID:28511854 phenobarbital multiple interactions ISO RGD:69039 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of IGFBP1 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of IGFBP1 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital affects expression ISO RGD:69038 6480464 Phenobarbital affects the expression of IGFBP1 mRNA CTD PMID:19084549 , PMID:19159669 phenobarbital increases secretion ISO RGD:69038 6480464 Phenobarbital results in increased secretion of IGFBP1 protein CTD PMID:12659874 phenobarbital increases expression ISO RGD:69038 6480464 Phenobarbital results in increased expression of IGFBP1 mRNA CTD PMID:12659874 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of IGFBP1 mRNA CTD PMID:19162173 phenobarbital increases expression ISO RGD:69039 6480464 Phenobarbital results in increased expression of IGFBP1 mRNA CTD PMID:19482888 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of IGFBP1 mRNA CTD PMID:15059925 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:69039 6480464 [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IGFBP1 mRNA CTD PMID:16368122 phorone affects expression EXP 6480464 phorone affects the expression of IGFBP1 mRNA CTD PMID:18198479 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of IGFBP1 mRNA CTD PMID:15890375 pirinixic acid multiple interactions ISO RGD:69039 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IGFBP1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:69039 6480464 pirinixic acid results in increased expression of IGFBP1 mRNA, pirinixic acid results in increased expression of IGFBP1 protein CTD PMID:12727805 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of IGFBP1 mRNA CTD PMID:15890375 potassium bromate increases expression EXP 6480464 potassium bromate results in increased expression of IGFBP1 mRNA CTD PMID:23588252 potassium dichromate decreases expression ISO RGD:69039 6480464 Potassium Dichromate results in decreased expression of IGFBP1 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of IGFBP1 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:69039 6480464 Pregnenolone Carbonitrile results in increased expression of IGFBP1 mRNA CTD PMID:28903501 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:69039 6480464 Pregnenolone Carbonitrile results in decreased expression of IGFBP1 mRNA CTD PMID:22698814 , PMID:27413110 progesterone affects expression ISO RGD:69038 6480464 Progesterone affects the expression of IGFBP1 mRNA, Progesterone affects the expression of IGFBP1 protein CTD PMID:15501902 progesterone increases expression ISO RGD:69038 6480464 Progesterone results in increased expression of IGFBP1 mRNA CTD PMID:17404688 more ... progesterone increases secretion ISO RGD:69038 6480464 Progesterone results in increased secretion of IGFBP1 protein CTD PMID:26604029 progesterone multiple interactions ISO RGD:69038 6480464 4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide inhibits the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]] more ... CTD PMID:17404688 more ... propanal decreases expression ISO RGD:69038 6480464 propionaldehyde results in decreased expression of IGFBP1 mRNA CTD PMID:26079696 quercetin decreases expression ISO RGD:69038 6480464 Quercetin results in decreased expression of IGFBP1 mRNA CTD PMID:21632981 quinolin-8-ol increases expression ISO RGD:69038 6480464 Oxyquinoline results in increased expression of IGFBP1 mRNA CTD PMID:21632981 resveratrol multiple interactions EXP 6480464 FOXO1 protein affects the reaction [resveratrol results in increased expression of IGFBP1 mRNA], resveratrol inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] CTD PMID:15788402 , PMID:16626303 resveratrol multiple interactions ISO RGD:69038 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of IGFBP1 mRNA CTD PMID:23557933 resveratrol increases expression ISO RGD:69038 6480464 resveratrol results in increased expression of IGFBP1 mRNA CTD PMID:12154049 resveratrol multiple interactions ISO RGD:69039 6480464 resveratrol promotes the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA] CTD PMID:16917544 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of IGFBP1 mRNA CTD PMID:16236254 riddelliine increases expression EXP 6480464 riddelliine results in increased expression of IGFBP1 mRNA CTD PMID:18047727 rifampicin multiple interactions ISO RGD:69038 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP1 mRNA CTD PMID:21127053 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Buthionine Sulfoximine inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] CTD PMID:17213664 silicon dioxide increases expression ISO RGD:69038 6480464 Silicon Dioxide analog results in increased expression of IGFBP1 mRNA CTD PMID:25895662 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of IGFBP1 mRNA CTD PMID:21865292 sodium arsenite multiple interactions ISO RGD:69039 6480464 [Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of IGFBP1 mRNA, [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IGFBP1 mRNA CTD PMID:16368122 , PMID:19665456 sodium arsenite decreases expression ISO RGD:69039 6480464 sodium arsenite results in decreased expression of IGFBP1 mRNA CTD PMID:17350061 , PMID:17451858 sodium arsenite increases expression ISO RGD:69039 6480464 sodium arsenite results in increased expression of IGFBP1 mRNA CTD PMID:14691202 more ... sodium arsenite affects expression ISO RGD:69039 6480464 sodium arsenite affects the expression of IGFBP1 mRNA CTD PMID:16507464 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of IGFBP1 mRNA CTD PMID:25993096 sotorasib multiple interactions ISO RGD:69038 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IGFBP1 mRNA CTD PMID:36139627 starch multiple interactions EXP 6480464 Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of IGFBP1 mRNA] CTD PMID:27363782 stavudine increases expression EXP 6480464 Stavudine results in increased expression of IGFBP1 mRNA CTD PMID:18299183 succimer multiple interactions ISO RGD:69038 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP1 mRNA CTD PMID:26378955 Sunset Yellow FCF multiple interactions ISO RGD:69038 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA CTD PMID:33819548 tacrolimus hydrate decreases expression EXP 6480464 Tacrolimus results in decreased expression of IGFBP1 mRNA CTD PMID:21865292 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of IGFBP1 mRNA CTD PMID:21865292 tamoxifen multiple interactions ISO RGD:69038 6480464 [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein CTD PMID:16847815 tamoxifen increases expression ISO RGD:69038 6480464 Tamoxifen results in increased expression of IGFBP1 mRNA CTD PMID:27089845 tamoxifen affects expression ISO RGD:69039 6480464 Tamoxifen affects the expression of IGFBP1 mRNA CTD PMID:20937368 tauroursodeoxycholic acid increases expression EXP 6480464 ursodoxicoltaurine results in increased expression of IGFBP1 mRNA CTD PMID:15885361 testosterone multiple interactions ISO RGD:69038 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of IGFBP1 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:69038 6480464 Testosterone results in decreased expression of IGFBP1 mRNA CTD PMID:21592394 tetrachloroethene increases expression ISO RGD:69039 6480464 Tetrachloroethylene results in increased expression of IGFBP1 mRNA CTD PMID:28973375 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of IGFBP1 mRNA CTD PMID:15963342 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IGFBP1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:69039 6480464 Carbon Tetrachloride results in increased expression of IGFBP1 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of IGFBP1 mRNA CTD PMID:15070850 more ... tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of IGFBP1 mRNA CTD PMID:17522070 tetracycline increases expression ISO RGD:69038 6480464 Tetracycline results in increased expression of IGFBP1 mRNA CTD PMID:27089845 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA CTD PMID:33854195 thioacetamide increases expression ISO RGD:69038 6480464 Thioacetamide results in increased expression of IGFBP1 mRNA CTD PMID:11793227 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IGFBP1 mRNA CTD PMID:16297948 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of IGFBP1 mRNA CTD PMID:14739098 thioacetamide multiple interactions EXP 6480464 halofuginone inhibits the reaction [Thioacetamide results in decreased expression of IGFBP1 mRNA] CTD PMID:14739098 tianeptine increases expression ISO RGD:69038 6480464 tianeptine results in increased expression of IGFBP1 mRNA CTD PMID:27089845 titanium dioxide increases expression ISO RGD:69039 6480464 titanium dioxide results in increased expression of IGFBP1 mRNA CTD PMID:23557971 tolcapone increases expression EXP 6480464 tolcapone results in increased expression of IGFBP1 mRNA CTD PMID:24136188 trametinib multiple interactions ISO RGD:69038 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IGFBP1 mRNA CTD PMID:36139627 tributylstannane decreases expression ISO RGD:69039 6480464 tributyltin results in decreased expression of IGFBP1 mRNA CTD PMID:31939706 trichloroethene increases expression ISO RGD:69039 6480464 Trichloroethylene results in increased expression of IGFBP1 mRNA CTD PMID:25549359 triclosan increases expression ISO RGD:69038 6480464 Triclosan results in increased expression of IGFBP1 mRNA CTD PMID:26604029 triclosan increases secretion ISO RGD:69038 6480464 Triclosan results in increased secretion of IGFBP1 protein CTD PMID:26604029 triclosan multiple interactions ISO RGD:69038 6480464 [Progesterone co-treated with Triclosan] results in increased expression of IGFBP1 mRNA, Progesterone promotes the reaction [Triclosan results in increased secretion of IGFBP1 protein] CTD PMID:26604029 Triptolide decreases expression ISO RGD:69039 6480464 triptolide results in decreased expression of IGFBP1 mRNA CTD PMID:32835833 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of IGFBP1 mRNA CTD PMID:23639586 tris(2-butoxyethyl) phosphate affects expression ISO RGD:69038 6480464 tris(2-butoxyethyl) phosphate affects the expression of IGFBP1 mRNA CTD PMID:29024780 troglitazone increases expression ISO RGD:69038 6480464 troglitazone results in increased expression of IGFBP1 mRNA CTD PMID:12659874 troglitazone decreases expression ISO RGD:69038 6480464 troglitazone results in decreased expression of IGFBP1 mRNA CTD PMID:25572481 troglitazone increases secretion ISO RGD:69038 6480464 troglitazone results in increased secretion of IGFBP1 protein CTD PMID:12659874 trovafloxacin multiple interactions ISO RGD:69039 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IGFBP1 mRNA CTD PMID:18930950 tunicamycin increases expression ISO RGD:69038 6480464 Tunicamycin results in increased expression of IGFBP1 mRNA CTD PMID:33545341 urethane increases expression ISO RGD:69038 6480464 Urethane results in increased expression of IGFBP1 mRNA CTD PMID:28818685 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of IGFBP1 mRNA CTD PMID:15885361 valproic acid affects expression ISO RGD:69039 6480464 Valproic Acid affects the expression of IGFBP1 mRNA CTD PMID:17963808 vancomycin affects expression EXP 6480464 Vancomycin affects the expression of IGFBP1 mRNA CTD PMID:18289764 vancomycin increases expression ISO RGD:69039 6480464 Vancomycin results in increased expression of IGFBP1 mRNA CTD PMID:18930951 vandetanib increases expression ISO RGD:69038 6480464 vandetanib results in increased expression of IGFBP1 mRNA CTD PMID:16052530 vemurafenib multiple interactions ISO RGD:69038 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of IGFBP1 protein CTD PMID:27169980 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP1 mRNA, Zinc deficiency results in decreased expression of IGFBP1 protein CTD PMID:12672911 , PMID:20404036 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP1 mRNA, Zinc deficiency results in decreased expression of IGFBP1 protein CTD PMID:12672911 , PMID:20404036
